Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK'S CEO Witty Takes The Appeasement Road On Drug Pricing In India
Forbes
Monday, November 25, 2013 - 10:59am
tags:
Andrew Witty, Pharma CEOs, India, GSK
Zerenex- The New Spark For Keryx?
Seeking Alpha
Monday, November 25, 2013 - 10:57am
tags:
Zerenex, Keryx, Sanofi, OPKO Health
Alnylam earns $7M payment for patisiran Phase II 'success'
The Fly on the Wall
Monday, November 25, 2013 - 10:44am
tags:
Alnylam, Patisiran, Genzyme, Sanofi
Drug developer Compugen sees boost from Bayer oncology deal
Yahoo/Reuters
Monday, November 25, 2013 - 10:41am
tags:
Bayer, CompuGen, oncology
Orexigen Weight-Loss Pill Passes Safety Hurdle
TheStreet.com
Monday, November 25, 2013 - 10:35am
tags:
Orexigen, obesity, Contrave, FDA, Takeda
Repligen - My Projections For The Income Statement: 2013-2019
Seeking Alpha
Monday, November 25, 2013 - 10:34am
tags:
Repligen
FDA Schedules Face to Face Meeting With Repros to Discuss Androxal(R) Efficacy
Yahoo
Monday, November 25, 2013 - 10:31am
tags:
Androxal, FDA, Repros, testosterone
4 Biotech Stocks With Upcoming FDA Decision Dates
Seeking Alpha
Monday, November 25, 2013 - 10:22am
tags:
FDA, Gilead, Auxilium, GSK, Theravance, sofosbuvir, Xiaflex, Anoro
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Forbes
Monday, November 25, 2013 - 9:12am
tags:
cholesterol, PCSK9 inhibitors, evolocumab, Amgen
Ampio Hides Need For New Eye Drug Study in SEC Filing
TheStreet.com
Monday, November 25, 2013 - 9:04am
tags:
Ampio Pharmaceuticals, SEC, Optina, Regeneron
Pfizer, Wyeth boards approve merger in India
Times of India
Monday, November 25, 2013 - 9:02am
tags:
India, Pfizer, Wyeth, M&A
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Monday, November 25, 2013 - 9:01am
tags:
Europe, JNJ, Novartis, pay-for-delay, generics, Sandoz, Fentanyl, pain patches
NeoStem: A Biotech In Need Of A Catalyst
Seeking Alpha
Monday, November 25, 2013 - 8:59am
tags:
NeoStem
Soros Increases Holdings in Teva to Most Since 2010
Bloomberg
Sunday, November 24, 2013 - 12:52pm
tags:
George Soros, Teva Pharmaceuticals
3 New Cholesterol Treatments Worth Watching
Motley Fool
Sunday, November 24, 2013 - 12:46pm
tags:
Sanofi, Regeneron, Amgen, alirocumab, AMG 145, RN-316, Pfizer
Ampio: Anticipating Data For Exciting DME Therapy Optina
Seeking Alpha
Sunday, November 24, 2013 - 12:43pm
tags:
Ampio Pharmaceuticals, Optina, diabetic macular edema
10-Bagger Returns Without R&D
Motley Fool
Sunday, November 24, 2013 - 12:31pm
tags:
Valeant Pharmaceuticals
Opportunities in Lung Cancer Therapies
Motley Fool
Sunday, November 24, 2013 - 12:30pm
tags:
lung cancer, non-small cell lung cancer, Avastin, Genentech, Roche, Tarceva, AstraZeneca, Iressa, Alimta, selumetinib, Array Biopharma, CO-1686, Clovis Oncology, AP26113, Ariad Pharmaceuticals
Sequenom: Is The Bottom In The Rearview Mirror?
Seeking Alpha
Sunday, November 24, 2013 - 12:26pm
tags:
Sequenom
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sunday, November 24, 2013 - 12:24pm
tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C, sofosbuvir, ABT-450, ABT-333, ABT-267

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.